TrialEuropean journal of ophthalmology2019

Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.

Kelly K Nichols et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.